Adam Greene is a Partner on the Therapeutics team and joined the Firm in 2010. Prior to Deerfield, he was a pharmaceutical analyst on the sell-side for seventeen years at several firms, including RBC Capital Markets, JPMorgan and First Albany. Throughout his career, Mr. Greene’s sell-side research was focused on generic drug manufacturers as well as large cap and specialty pharmaceuticals. Mr. Greene holds a B.S. in Finance from Lehigh University.